2020
DOI: 10.1097/xeb.0000000000000262
|View full text |Cite
|
Sign up to set email alerts
|

Immunosuppressive adherence after kidney transplantation in adult patients treated at an outpatient clinic: a better practice implementation project

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
2
0
1
Order By: Relevance
“…However, with gradual enhancement of kidney cell injury, the patient’s kidney self-repair ability is eventually lost. By this time, kidney transplantation or dialysis treatment is usually required, which seriously threatens a patient’s life[ 17 , 18 ]. Guo et al [ 19 ] analyzed the HbA1c level of patients with DN, and showed that the determination of HbA1c level in patients has a positive effect on early kidney injury.…”
Section: Discussionmentioning
confidence: 99%
“…However, with gradual enhancement of kidney cell injury, the patient’s kidney self-repair ability is eventually lost. By this time, kidney transplantation or dialysis treatment is usually required, which seriously threatens a patient’s life[ 17 , 18 ]. Guo et al [ 19 ] analyzed the HbA1c level of patients with DN, and showed that the determination of HbA1c level in patients has a positive effect on early kidney injury.…”
Section: Discussionmentioning
confidence: 99%
“…'nın yaptıkları çalışmada aile üyelerinin desteğinin immünosupresif uyumunun artmasında önemli bir faktör olduğu belirtilmiştir. 24 Bu çalışmada da benzer şekilde evli olan ve ilaç kullanımına yardımcı kişi olan katılımcılarda İTUÖ toplam puanları daha yüksek bulundu (Tablo 2). Bunun nedeni evde başka birinin varlığının ilaç kullanımında hatırlatıcı, motive edici, destek verici etkisiyle açıklanabilir.…”
Section: Böbrek Nakli Hastaları İçin İlaç İzlem Formuunclassified
“…Epidemiological studies have shown that the number of patients with DKD is increasing year by year, and it is estimated that there will be 592 million patients with DKD by 2035, accounting for about 8%–10% of the global population ( 4 , 5 ). Renal failure in patients with advanced DKD often requires renal replacement therapy or renal transplantation, which seriously jeopardizes the physical and mental health of patients and imposes a substantial economic burden on families and society ( 6 ). Currently, the main therapeutic options for DKD include hypoglycemia, antihypertensive, regulation of lipid metabolism disorders, reduction of urinary protein, and renal replacement therapy for end-stage renal disease ( 7 ).…”
Section: Introductionmentioning
confidence: 99%